Prenumeration
Kalender
Est. tid* | ||
2025-11-27 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-28 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-06-25 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
2025-06-24 | - | Årsstämma |
2025-06-10 | - | Extra Bolagsstämma 2025 |
2025-05-30 | - | Kvartalsrapport 2025-Q1 |
2025-02-28 | - | Bokslutskommuniké 2024 |
2024-11-27 | - | Kvartalsrapport 2024-Q3 |
2024-08-28 | - | Kvartalsrapport 2024-Q2 |
2024-05-27 | - | Årsstämma |
2024-05-17 | - | Kvartalsrapport 2024-Q1 |
2024-05-15 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
2024-02-21 | - | Bokslutskommuniké 2023 |
2023-11-27 | - | Extra Bolagsstämma 2023 |
2023-11-27 | - | Kvartalsrapport 2023-Q3 |
2023-08-29 | - | Kvartalsrapport 2023-Q2 |
2023-05-12 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
2023-05-11 | - | Årsstämma |
2023-05-11 | - | Kvartalsrapport 2023-Q1 |
2023-02-21 | - | Bokslutskommuniké 2022 |
2022-11-30 | - | Kvartalsrapport 2022-Q3 |
2022-08-29 | - | Kvartalsrapport 2022-Q2 |
2022-08-04 | - | Extra Bolagsstämma 2022 |
2022-05-23 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
2022-05-20 | - | Årsstämma |
2022-05-20 | - | Kvartalsrapport 2022-Q1 |
2022-02-22 | - | Bokslutskommuniké 2021 |
2021-11-23 | - | Kvartalsrapport 2021-Q3 |
2021-08-31 | - | Kvartalsrapport 2021-Q2 |
2021-05-06 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
2021-05-05 | - | Årsstämma |
2021-05-05 | - | Kvartalsrapport 2021-Q1 |
2021-02-24 | - | Bokslutskommuniké 2020 |
2020-11-17 | - | Kvartalsrapport 2020-Q3 |
2020-08-28 | - | Kvartalsrapport 2020-Q2 |
2020-05-21 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
2020-05-20 | - | Årsstämma |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-02-13 | - | Bokslutskommuniké 2019 |
2019-11-20 | - | Kvartalsrapport 2019-Q3 |
2019-08-28 | - | Kvartalsrapport 2019-Q2 |
2019-05-16 | - | Årsstämma |
2019-05-16 | - | Kvartalsrapport 2019-Q1 |
2019-05-10 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
2018-11-20 | - | Kvartalsrapport 2018-Q3 |
2018-08-28 | - | Kvartalsrapport 2018-Q2 |
2018-05-17 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
2018-05-16 | - | Årsstämma |
2018-05-16 | - | Kvartalsrapport 2018-Q1 |
2018-02-14 | - | Bokslutskommuniké 2017 |
2017-11-23 | - | Kvartalsrapport 2017-Q3 |
2017-08-25 | - | Kvartalsrapport 2017-Q2 |
2017-05-22 | - | X-dag ordinarie utdelning PRLD 0.00 SEK |
2017-05-19 | - | Årsstämma |
2017-05-19 | - | Kvartalsrapport 2017-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Nordic SME Sweden |
Sektor | Hälsovård |
Industri | Medicinteknik |
Prolight Diagnostics AB will display a fully functioning commercial prototype of its groundbreaking Psyros Digital point of care IVD platform at the Association for Diagnostics & Laboratory Medicine (ADLM) 2025, in Chicago July 27th–29th.
This marks the first public display of the company’s fully functioning Psyros™ prototype, developed to deliver rapid,
lab-quality results at the point of care. Compact, user-friendly, and highly versatile, the prototype embodies Prolight’s mission to transform how and where diagnostics are delivered – bringing advanced testing closer to patients and clinicians.
“Presenting our commercial prototype at ADLM 2025 is a significant step forward,” said Ulf Bladin, CEO at Prolight. “We are excited to demonstrate not just a concept, but a ready-to-scale solution designed to support faster clinical decisions and better patient outcomes.”
Visitors to Prolight’s booth will have the opportunity to get up close with the device and meet the team behind its development. The company is also inviting key potential partners, investors, and healthcare professionals to demonstrations of the instrument.
ADLM 2025 is the premier annual gathering for laboratory medicine professionals - combining a scientific educational conference, innovation showcase, and global networking opportunity.
Event Details:
ADLM 2025 (formerly AACC Annual Scientific Meeting & Clinical Lab Expo)
Location: Chicago, IL
Dates: 27th to 31st July, 2025
Booth #: DxPX Area Booth 09
For further information, please contact:
Ulf Bladin, CEO
E-mail: info@prolightdx.com
Phone: +46 73 582 39 87
Company website: www.prolightdx.com
About Us
Prolight Diagnostics AB develops innovative Point-of-Care systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of high sensitive troponin, to aid in the rule-in and rule-out of myocardial infarction.
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.